Camp4 Therapeutics Corp insider trading
Every open-market purchase and sale by Camp4 Therapeutics Corp's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
Insider purchases, 5 years $99,051 5 trades by 4 insiders
3 months later: median −10.3% (−9.8% vs S&P 500) Insider sales, 5 years $2.5M 6 trades by 2 insiders
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Camp4 Therapeutics Corp’s insiders pay?
From September 11, 2025 to September 2, 2026, 7 insiders reported 8 open-market purchases and 2 sales not made under a pre-set plan in Camp4 Therapeutics Corp.
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Gold Kelly | Chief Financial Officer | 2 | — | — | 0 | — | September 2, 2026 |
| Schwab Andrew J. | Director | 0 | — | — | 2 | — | August 31, 2026 |
| Young Richard A | Director | 2 | — | — | 0 | — | August 5, 2026 |
| 5am Ventures VII, L.P. | 10% owner | 1 | — | — | 0 | — | September 15, 2025 |
| Mandel-Brehm Josh | Chief Executive Officer | 1 | — | — | 0 | — | August 5, 2026 |
| Maricich Yuri | Chief Medical Officer | 1 | — | — | 0 | — | August 5, 2026 |
| Nashat Amir | Director | 1 | — | — | 0 | — | September 11, 2025 |